AU1510183A - Lupus assay method and compositions - Google Patents

Lupus assay method and compositions

Info

Publication number
AU1510183A
AU1510183A AU15101/83A AU1510183A AU1510183A AU 1510183 A AU1510183 A AU 1510183A AU 15101/83 A AU15101/83 A AU 15101/83A AU 1510183 A AU1510183 A AU 1510183A AU 1510183 A AU1510183 A AU 1510183A
Authority
AU
Australia
Prior art keywords
liposomes
phosphatidylcholine
liposome
composition according
phosphatidic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15101/83A
Other languages
English (en)
Inventor
A.S. Janoff
M.J. Ostro
J.R Seibold
A.L. Weiner
G. Weissmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of AU1510183A publication Critical patent/AU1510183A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU15101/83A 1982-03-26 1983-03-24 Lupus assay method and compositions Abandoned AU1510183A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36238282A 1982-03-26 1982-03-26
US362382 1982-03-26
US41024982A 1982-08-23 1982-08-23
US410249 1982-08-23

Publications (1)

Publication Number Publication Date
AU1510183A true AU1510183A (en) 1983-10-24

Family

ID=27001661

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15101/83A Abandoned AU1510183A (en) 1982-03-26 1983-03-24 Lupus assay method and compositions

Country Status (5)

Country Link
JP (1) JPS59500529A (da)
AU (1) AU1510183A (da)
DK (1) DK541883D0 (da)
NO (1) NO834349L (da)
WO (1) WO1983003473A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957735A (en) * 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
US4865970A (en) * 1986-02-28 1989-09-12 Hoffmann-La Roche Inc. Method of detecting ribosomal protein antibodies in systemic lupus erythematosus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4255411A (en) * 1978-11-27 1981-03-10 Damon Corporation Process of determining an immunogenic substance by competition with an antibody in a microcapsule
US4372745A (en) * 1979-12-19 1983-02-08 Electro-Nucleonics, Inc. Chemical luminescence amplification substrate system for immunochemistry involving microencapsulated fluorescer
US4342826A (en) * 1980-02-04 1982-08-03 Collaborative Research, Inc. Immunoassay products and methods

Also Published As

Publication number Publication date
DK541883A (da) 1983-11-25
DK541883D0 (da) 1983-11-25
NO834349L (no) 1983-11-25
WO1983003473A1 (en) 1983-10-13
JPS59500529A (ja) 1984-03-29

Similar Documents

Publication Publication Date Title
US4564599A (en) Liposome composition for lupus assay
US4668638A (en) Liposome composition for lupus assay
Kinsky [47] Preparation of liposomes and a spectrophotometric assay for release of trapped glucose marker
Duzgunes et al. Lipid mixing during membrane aggregation and fusion: why fusion assays disagree
Lichtenberg et al. Liposomes: preparation, characterization, and preservation
Mansbach et al. Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man.
Tanford et al. Characterization of membrane proteins in detergent solutions
Lis et al. Interactions between neutral phospholipid bilayer membranes
US5580735A (en) Stabilized microspheres and methods of preparation
Conrad et al. Solubility of amphipathic molecules in biological membranes and lipid bilayers and its implications for membrane structure
Paternostre et al. Partition coefficient of a surfactant between aggregates and solution: application to the micelle-vesicle transition of egg phosphatidylcholine and octyl beta-D-glucopyranoside
Nichols et al. Kinetics of soluble lipid monomer diffusion between vesicles
US4704355A (en) Assay utilizing ATP encapsulated within liposome particles
Rice-Evans et al. Alterations in erythrocyte membrane fluidity by phenylhydrazine-induced peroxidation of lipids
Inoue et al. Effect of exogenous lysolecithin of liposomal membranes its relation to membrane fluidity
EP0212989B1 (en) Lipid vesicles containing labeled species and their analytical uses
Martin et al. Lipid vesicle-cell interactions. I. Hemagglutination and hemolysis.
Sweet et al. The binding of serum albumin to phospholipid liposomes
Nishida et al. Disruption of low-and high-density human plasma lipoproteins and phospholipid dispersions by 1-anilinonaphthalene-8-sulfonate
Alving et al. Immune reactivities of antibodies against glycolipids—I: Properties of anti-galactocerebroside antibodies purified by a novel technique of affinity binding to liposomes
AU1510183A (en) Lupus assay method and compositions
CA1201382A (en) Lupus assay method and composition
EP0518319B1 (en) Liposome immunoassays for detection of antigens, antibodies and haptens
Van der Meer et al. Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids
Harris The proteins released from intact erythrocyte ghosts' at low ionic strength.